These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 32735147)

  • 21. Current development of integrated web servers for preclinical safety and pharmacokinetics assessments in drug development.
    Hsiao Y; Su BH; Tseng YJ
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32770190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
    Khakar PS
    Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De-risking drug discovery with ADDME -- avoiding drug development mistakes early.
    Tsaioun K; Jacewicz M
    Altern Lab Anim; 2009 Sep; 37 Suppl 1():47-55. PubMed ID: 19807206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive Modelling in pharmacokinetics: from in-silico simulations to personalized medicine.
    Paliwal A; Jain S; Kumar S; Wal P; Khandai M; Khandige PS; Sadananda V; Anwer MK; Gulati M; Behl T; Srivastava S
    Expert Opin Drug Metab Toxicol; 2024 Apr; 20(4):181-195. PubMed ID: 38480460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The application of in silico drug-likeness predictions in pharmaceutical research.
    Tian S; Wang J; Li Y; Li D; Xu L; Hou T
    Adv Drug Deliv Rev; 2015 Jun; 86():2-10. PubMed ID: 25666163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. admetSAR3.0: a comprehensive platform for exploration, prediction and optimization of chemical ADMET properties.
    Gu Y; Yu Z; Wang Y; Chen L; Lou C; Yang C; Li W; Liu G; Tang Y
    Nucleic Acids Res; 2024 Jul; 52(W1):W432-W438. PubMed ID: 38647076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico ADMET prediction: recent advances, current challenges and future trends.
    Cheng F; Li W; Liu G; Tang Y
    Curr Top Med Chem; 2013; 13(11):1273-89. PubMed ID: 23675935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 1: goals, properties of the PhRMA dataset, and comparison with literature datasets.
    Poulin P; Jones HM; Jones RD; Yates JW; Gibson CR; Chien JY; Ring BJ; Adkison KK; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Ku MS
    J Pharm Sci; 2011 Oct; 100(10):4050-73. PubMed ID: 21523782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic properties and in silico ADME modeling in drug discovery.
    Honório KM; Moda TL; Andricopulo AD
    Med Chem; 2013 Mar; 9(2):163-76. PubMed ID: 23016542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computational Biology and Chemistry in MTi: Emphasis on the Prediction of Some ADMET Properties.
    Miteva MA; Villoutreix BO
    Mol Inform; 2017 Oct; 36(10):. PubMed ID: 28221002
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Ekins S; Lane TR; Urbina F; Puhl AC
    Xenobiotica; 2024 Jul; 54(7):352-358. PubMed ID: 37539466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computer-aided Drug Design and Drug Pharmacokinetic Prediction: A Mini-review.
    Tabeshpour J; Sahebkar A; Zirak MR; Zeinali M; Hashemzaei M; Rakhshani S; Rakhshani S
    Curr Pharm Des; 2018; 24(26):3014-3019. PubMed ID: 30179125
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of ADME characteristics in drug discovery and their in silico evaluation: in silico screening of chemicals for their metabolic stability.
    Gombar VK; Silver IS; Zhao Z
    Curr Top Med Chem; 2003; 3(11):1205-25. PubMed ID: 12769701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Silico Meets In Vitro Techniques in ADMET Profiling of Drug Discovery (Part I).
    Kar S; Chatterjee S
    Curr Drug Metab; 2020; 21(10):745. PubMed ID: 33327905
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular networks in drug discovery.
    Morrow JK; Tian L; Zhang S
    Crit Rev Biomed Eng; 2010; 38(2):143-56. PubMed ID: 20932236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J; Skolnik S
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In Silico Tools to Thaw the Complexity of the Data: Revolutionizing Drug Research in Drug Metabolism, Pharmacokinetics and Toxicity Prediction.
    Kommalapati HS; Pilli P; Golla VM; Bhatt N; Samanthula G
    Curr Drug Metab; 2023; 24(11):735-755. PubMed ID: 38058088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDK-Taverna: an open workflow environment for cheminformatics.
    Kuhn T; Willighagen EL; Zielesny A; Steinbeck C
    BMC Bioinformatics; 2010 Mar; 11():159. PubMed ID: 20346188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Discovering best candidates for Hepatocellular Carcinoma (HCC) by in-silico techniques and tools.
    Mabrouk MS
    Int J Bioinform Res Appl; 2012; 8(1-2):141-52. PubMed ID: 22450276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent Advances of Computational Modeling for Predicting Drug Metabolism: A Perspective.
    Kar S; Leszczynski J
    Curr Drug Metab; 2017; 18(12):1106-1122. PubMed ID: 28595533
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.